We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Daiichi Sankyo, Inc. and American Regent, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® for the treatment of iron deficiency anemia (IDA) in adult patients